Arun Ratn
Arun Ratn has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Divakar Sharma
Department of Biotechnology Graphic Era (Deemed to be) University Dehradun India
3 shared publications - Indu Singh
School of Pharmacy Graphic Era Hill University Dehradun India
3 shared publications - Anil Kumar
Veer Chandra Singh Garhwali Government Institute of Medical Science and Research
2 shared publications - Anusha Sharma
Dr Baba Saheb Ambedkar Medical College
1 shared publication - Anushri Keshri
Department of Biotechnology Holy Cross Women's College Ambikapur Chhattisgarh India
1 shared publication - Arun Kumar
Department of Biotechnology School of Basic and Applied Sciences Shri Guru Ram Rai University Dehradun India
1 shared publication
Latest Publications
- 1 March 2026
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 27
Adeno-associated virus (AAV) mediated advanced therapeutic interventions for inherited and non-inherited cardiac disorders
Introduction: Cardiovascular diseases remain the leading cause of global morbidity and mortality, driven by a complex interplay of inherited and acquired factors that limit the long-term effectiveness of conventional pharmacological, surgical, and device-based therapies. Recent advances in gene therapy have positioned adeno-associated virus (AAV) vectors as a promising platform for addressing the molecular determinants of both inherited and non-inherited cardiac disorders. Owing to their favourable safety profile, low pathogenicity, sustained transgene expression, and broad tissue tropism, AAV vectors have evolved as the most comprehensively evaluated viral delivery system in cardiovascular gene therapy. Method: This classical review was compiled after a comprehensive literature search of major scientific databases, including PubMed, Scopus, and Web of Science, using keywords related to adeno-associated virus, therapies, inherited and non-inherited cardiac disorders. This review provides a comprehensive synthesis of the biological properties of AAV vectors, with emphasis on serotype-specific cardiac tropism, receptor usage, immunogenicity, and durability of gene expression. We critically assess preclinical and clinical evidence supporting AAV-mediated gene delivery across a spectrum of cardiac conditions, including heart failure, cardiomyopathies, ischemic heart disease, and inherited arrhythmias, highlighting both therapeutic successes and translational limitations. Conclusions: This review highlights the current delivery strategies, genetic cargoes, and emerging genome-editing approaches, which are discussed in the context of efficacy and safety. Key challenges-such as pre-existing immunity, dose-dependent toxicity, off-target transduction, manufacturing scalability, regulatory constraints, and clinical trial design-are analysed to delineate barriers to widespread clinical adoption. Finally, we outline future directions focused on rational capsid engineering, tissue-specific targeting, improved manufacturing pipelines, and optimized clinical strategies required to advance AAV-based gene therapy toward durable and accessible treatments for cardiac diseases.
- 1 March 2026
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 27
Adeno-associated virus (AAV) mediated advanced therapeutic interventions for inherited and non-inherited cardiac disorders
Introduction: Cardiovascular diseases remain the leading cause of global morbidity and mortality, driven by a complex interplay of inherited and acquired factors that limit the long-term effectiveness of conventional pharmacological, surgical, and device-based therapies. Recent advances in gene therapy have positioned adeno-associated virus (AAV) vectors as a promising platform for addressing the molecular determinants of both inherited and non-inherited cardiac disorders. Owing to their favourable safety profile, low pathogenicity, sustained transgene expression, and broad tissue tropism, AAV vectors have evolved as the most comprehensively evaluated viral delivery system in cardiovascular gene therapy. Method: This classical review was compiled after a comprehensive literature search of major scientific databases, including PubMed, Scopus, and Web of Science, using keywords related to adeno-associated virus, therapies, inherited and non-inherited cardiac disorders. This review provides a comprehensive synthesis of the biological properties of AAV vectors, with emphasis on serotype-specific cardiac tropism, receptor usage, immunogenicity, and durability of gene expression. We critically assess preclinical and clinical evidence supporting AAV-mediated gene delivery across a spectrum of cardiac conditions, including heart failure, cardiomyopathies, ischemic heart disease, and inherited arrhythmias, highlighting both therapeutic successes and translational limitations. Conclusions: This review highlights the current delivery strategies, genetic cargoes, and emerging genome-editing approaches, which are discussed in the context of efficacy and safety. Key challenges-such as pre-existing immunity, dose-dependent toxicity, off-target transduction, manufacturing scalability, regulatory constraints, and clinical trial design-are analysed to delineate barriers to widespread clinical adoption. Finally, we outline future directions focused on rational capsid engineering, tissue-specific targeting, improved manufacturing pipelines, and optimized clinical strategies required to advance AAV-based gene therapy toward durable and accessible treatments for cardiac diseases.
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1)
Coagulase‐Negative Staphylococci (CoNS): An Emerging Threat, Antimicrobial Resistance, and Health Concern
Coagulase‐negative staphylococci (CoNS) have evolved from a harmless commensal group to an alarming threat to patient, environmental, and population health due to their challenging treatment and their impact on health outcomes. The widespread presence of CoNS in these environments poses a public health concern due to various virulence factors, biofilm formation, and toxin production, which contribute to pathogenicity and antimicrobial resistance (AMR). Major clinical manifestations include device‐related infections, bloodstream infections, and neonatal sepsis. Nonclinical reservoirs, such as soil, water, animals, and food‐processing environments, are considered critical sources of resistance gene flow. The mechanisms of resistance include the mecA gene and a variety of SCCmec elements, as well as horizontal gene transfer via plasmids and transposons, and tolerance via biofilm formation. This review summarizes current findings on the epidemiology, AMR mechanisms, biofilm‐linked pathogenicity, diagnostic advances, and One Health implementations of CoNS across nonclinical and clinical contexts, while recognizing priorities for therapeutic and surveillance development. Here, the reviewed literature suggests considerable variation in drug resistant CoNS and distribution landscapes across nonclinical and clinical contexts, with MGEs, biofilm establishment, and environmental repertoires reflecting imperative determinants in the dissemination and persistence of AMR. An analysis of the existing literature indicates that genetic links between clinical and environmental isolates remain insufficiently established and that surveillance data are lacking; accordingly, future research should focus on these gaps. Addressing the threat of CoNS requires enhanced surveillance, improved diagnostic precision, and the development of novel antimicrobial and antibiofilm strategies. Future research should focus on epidemiological surveillance, innovation in therapy, and systems‐based approaches, which consider the interrelationship of human, animal, and environmental health.
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1)
Open AccessCoagulase‐Negative Staphylococci (CoNS): An Emerging Threat, Antimicrobial Resistance, and Health Concern
Coagulase‐negative staphylococci (CoNS) have evolved from a harmless commensal group to an alarming threat to patient, environmental, and population health due to their challenging treatment and their impact on health outcomes. The widespread presence of CoNS in these environments poses a public health concern due to various virulence factors, biofilm formation, and toxin production, which contribute to pathogenicity and antimicrobial resistance (AMR). Major clinical manifestations include device‐related infections, bloodstream infections, and neonatal sepsis. Nonclinical reservoirs, such as soil, water, animals, and food‐processing environments, are considered critical sources of resistance gene flow. The mechanisms of resistance include the mecA gene and a variety of SCCmec elements, as well as horizontal gene transfer via plasmids and transposons, and tolerance via biofilm formation. This review summarizes current findings on the epidemiology, AMR mechanisms, biofilm‐linked pathogenicity, diagnostic advances, and One Health implementations of CoNS across nonclinical and clinical contexts, while recognizing priorities for therapeutic and surveillance development. Here, the reviewed literature suggests considerable variation in drug resistant CoNS and distribution landscapes across nonclinical and clinical contexts, with MGEs, biofilm establishment, and environmental repertoires reflecting imperative determinants in the dissemination and persistence of AMR. An analysis of the existing literature indicates that genetic links between clinical and environmental isolates remain insufficiently established and that surveillance data are lacking; accordingly, future research should focus on these gaps. Addressing the threat of CoNS requires enhanced surveillance, improved diagnostic precision, and the development of novel antimicrobial and antibiofilm strategies. Future research should focus on epidemiological surveillance, innovation in therapy, and systems‐based approaches, which consider the interrelationship of human, animal, and environmental health.
- 30 June 2025
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 26
Epithelial sodium channels: Tissue distribution, function, and regulation by mineralocorticoid aldosterone
The epithelial sodium channel (ENaC) is made up of three subunits (αβγ or δβγ), and the predominant ENaC consists of αβγ subunits, regulating the homeostasis of fluids and sodium ions. ENaC controls blood pressure and volume by reabsorbing fluid from the kidneys into the blood. ENaC also maintains fluids in the colon and the normal airway surface in the lung and other epithelial cells. Investigations on ENaC showed that it is also found in non-epithelial cells and tissues like neurons and endothelial cells of blood vessels. Recent investigations have demonstrated that ENaC is regulated by various proteins (SGK-1, NEDD4-2, AMPK, mTORC2, WNKs, proteases, and AKT), ions (Na + ), hormones (vasopressin, aldosterone, and glucocorticoids), and even by post-translational modifications (acetylation, glycosylation, palmitoylation, phosphorylation, and de-ubiquitylation). From a clinical perspective, abnormal expression of ENaC gives rise to various clinical conditions like Liddle syndrome (hereditary hypertension), pseudohypoaldosteronism type-1, and cystic fibrosis (polymorphism in ENaC). This review emphasizes the distribution, structure, and function of ENaC, as well as its clinical importance. We also shed light on the aspects of ENaC regulations and clinical conditions developed owing to ENaC alterations.
- 30 June 2025
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 26
Epithelial sodium channels: Tissue distribution, function, and regulation by mineralocorticoid aldosterone
The epithelial sodium channel (ENaC) is made up of three subunits (αβγ or δβγ), and the predominant ENaC consists of αβγ subunits, regulating the homeostasis of fluids and sodium ions. ENaC controls blood pressure and volume by reabsorbing fluid from the kidneys into the blood. ENaC also maintains fluids in the colon and the normal airway surface in the lung and other epithelial cells. Investigations on ENaC showed that it is also found in non-epithelial cells and tissues like neurons and endothelial cells of blood vessels. Recent investigations have demonstrated that ENaC is regulated by various proteins (SGK-1, NEDD4-2, AMPK, mTORC2, WNKs, proteases, and AKT), ions (Na + ), hormones (vasopressin, aldosterone, and glucocorticoids), and even by post-translational modifications (acetylation, glycosylation, palmitoylation, phosphorylation, and de-ubiquitylation). From a clinical perspective, abnormal expression of ENaC gives rise to various clinical conditions like Liddle syndrome (hereditary hypertension), pseudohypoaldosteronism type-1, and cystic fibrosis (polymorphism in ENaC). This review emphasizes the distribution, structure, and function of ENaC, as well as its clinical importance. We also shed light on the aspects of ENaC regulations and clinical conditions developed owing to ENaC alterations.
- Open Access
- 30 August 2022
- Published by International Journal of Development Research in International Journal of Development Research
- p. 58223-58226
Impact of deltamethrin (2.8% ec) on serum biochemistry and histopathology of fish, channa punctatus (bloch 1793)
A Pedagogia da Alternância apresenta princípio pedagógico desenvolvido nas Escolas Famílias Agrícolas (EFAs). Trata-se uma metodologia de ensino que faz parte dos pilares que rege esse modelo de escola, que contribui para o desenvolvimento socioambiental das comunidades rurais onde atuam, de modo a evitar o êxodo dos jovens para a cidade, incentivando a elaboração de propostas concretas voltadas para o trabalho no campo e valorização da cultura e modo de vida inerentes a estas comunidades. Este artigo possui como objetivo geral analisar os impactos da metodologia da pedagogia da alternância na EFAC, na aprendizagem dos ex-alunos do 3º ano do ensino médio. Realizou-se uma abordagem quanti-qualitativa, por meio de estudo de caso. A maior contribuição para escolas do campo é quanto ao sentido do saber e do fazer, aproximando a escola do meio e o aluno da comunidade.
- 30 August 2022
- Published by International Journal of Development Research in International Journal of Development Research
- p. 58223-58226
Open AccessImpact of deltamethrin (2.8% ec) on serum biochemistry and histopathology of fish, channa punctatus (bloch 1793)
A Pedagogia da Alternância apresenta princípio pedagógico desenvolvido nas Escolas Famílias Agrícolas (EFAs). Trata-se uma metodologia de ensino que faz parte dos pilares que rege esse modelo de escola, que contribui para o desenvolvimento socioambiental das comunidades rurais onde atuam, de modo a evitar o êxodo dos jovens para a cidade, incentivando a elaboração de propostas concretas voltadas para o trabalho no campo e valorização da cultura e modo de vida inerentes a estas comunidades. Este artigo possui como objetivo geral analisar os impactos da metodologia da pedagogia da alternância na EFAC, na aprendizagem dos ex-alunos do 3º ano do ensino médio. Realizou-se uma abordagem quanti-qualitativa, por meio de estudo de caso. A maior contribuição para escolas do campo é quanto ao sentido do saber e do fazer, aproximando a escola do meio e o aluno da comunidade.
- 1 September 2017
- Published by Elsevier in Chemosphere
- Vol. 182, 382-391
Phorate induced oxidative stress, DNA damage and differential expression of p53, apaf-1 and cat genes in fish, Channa punctatus (Bloch, 1793)
- 1 September 2017
- Published by Elsevier in Chemosphere
- Vol. 182, 382-391
Phorate induced oxidative stress, DNA damage and differential expression of p53, apaf-1 and cat genes in fish, Channa punctatus (Bloch, 1793)